Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations.
10.3760/cma.j.issn.0253-2727.2014.07.019
- VernacularTitle:FLAG方案诱导FLT3突变急性髓系白血病缓解后IBu方案预处理的自体造血干细胞移植疗效分析
- Author:
Biao WANG
1
;
Bin YANG
1
;
Weimin DONG
1
;
Deliang LIU
1
;
Yun LING
1
;
Xiangshan CAO
1
Author Information
1. Department of Haematology, The Third Affiliated Hospital of Soochow Medical University, Changzhou 213003, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Cytarabine;
therapeutic use;
Female;
Follow-Up Studies;
Granulocyte Colony-Stimulating Factor;
therapeutic use;
Hematopoietic Stem Cell Transplantation;
Humans;
Induction Chemotherapy;
Leukemia, Myeloid, Acute;
drug therapy;
genetics;
therapy;
Male;
Middle Aged;
Transplantation Conditioning;
Transplantation, Autologous;
Treatment Outcome;
Vidarabine;
analogs & derivatives;
therapeutic use;
fms-Like Tyrosine Kinase 3;
genetics
- From:
Chinese Journal of Hematology
2014;35(7):653-655
- CountryChina
- Language:Chinese
